期刊文献+

氯沙坦和氨氯地平对高血压病患者血压、血尿酸的作用比较 被引量:2

Comparison of effect of losartan on blood pressure and uric acid with amlodipine in patients with hypertesion
下载PDF
导出
摘要 [目的]比较氯沙坦和氨氯地平的降压疗效和对血尿酸的影响。[方法]选择大连医科大学第二临床学院北院心内科住院的高血压病人98例,随机分为两组:A组49例,晨服单一药氯沙坦50 mg/d;B组49例,晨服单一药氨氯地平5 mg/d,观察8周。治疗前后测血压、血尿酸。[结果]与用药前比较,服药8周后,两组血压均显著下降(P<0.01),组间无差异(P>0.05);两组血尿酸均下降,与用药前比较,氯沙坦组下降显著(P<0.05),氨氯地平组下降无显著性(P>0.05)。[结论]氯沙坦与氨氯地平降压疗效相似,均可作为抗高血压一线用药。其中,氯沙坦对高尿酸血症的患者尤为首选。 [ Objective] Comparison of the effect of losartan on blood pressure and uric acid with amlodipine. [ Methods] Ninty- eight aged patients with hypertension were randomly divided into group A and group B. The patients of group A received losartan 50mg qd; the patients of group B received amlodipine 5mg qd. The time of treatment was 8 weeks. Blood pressure was measured every other week. The changes of blood pressure and the serum uric acid in the end of week 8 were measured. [ Results] The blood pressure were significantly decreased on week 8 in group A and group B (P 〈 0.01 ), and the decrease in diastolic pressure and systolic pressure in group A and group B did not differ significantly ( P 〉 0.05). While hyperuricemia were significantly decreased in losartan group ( P 〈 0.05); Serum uric acid was not changed in amlodipine group (P 〉 0.05). [Conclusion] Losartan has the same effect of decreasing blood pressure with amlodipine, but losartan also decreases serum uric acid besides decreasing bloodpressure. For the patient with hypertension compamied by hyperuricemia , losarten is the first choice of decreasing blood pressure.
作者 刘艳
出处 《大连医科大学学报》 CAS 2006年第3期222-223,共2页 Journal of Dalian Medical University
关键词 氯沙坦 氨氯地平 高血压 血尿酸 amlodipine losarten hypertension serum uric acid
  • 相关文献

参考文献6

二级参考文献19

  • 1[1]Jossa F,Farinaro E,Panico S,et al. J Hum Hypertens, 1994; 8 (9): 677 ~ 681
  • 2[2]Abbott RD,Brand FN,Kannel WB,et al. J Clin Epidemiol, 1988; 41 (3): 237 ~ 242
  • 3[3]Freedman DS, Williamson DF, Gunter EW, et al. Am J Epidemiol, 1995; 141 (7): 637~ 644
  • 4[4]Tykarski A. Nephron,1991;59(3):364~368
  • 5[5]Alderman MH, Cohen H, Madhavan S, et al.Hypertension, 1999; 34(1): 144~ 150
  • 6[6]Bengtsson C, Lapidus L,Stendahl C, et al. Acta Med Scand,1988; 224 (6): 549~ 555
  • 7[7]Casiglia E, Spolaore P,Ginocchio G, et al. Eur J Epidemiol, 1993; 9(6): 577~ 586
  • 8[8]Lehto S,Niskanen L, Ronnemaa T, et al.Stroke, 1998;29(3) :635~639
  • 9[9]Roch - Ramel F, Guisan B, Diezi J. Pharmcol Exp Ther, 1997;280(2) :839~845
  • 10[10]Rieder MJ,Roman RJ,Greene AS. Hypertension, 1997; 30( 1 pt 1 ): 120~ 127

共引文献206

同被引文献21

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部